What the labels list, and what they do not
Searching the full US prescribing information, the EU product information and the Canadian monograph for brain fog, memory or cognition finds no adverse-reaction entry. Concentration and confusion appear only in one context: as signs of low blood sugar. The effects below are the listed ones that most often overlap with a foggy head.
| Listed effect | US label [1] | EU summary [2] | Canadian monograph [3] |
|---|---|---|---|
| Low blood sugar with insulin or a sulfonylurea | Warning 5.5; confusion or drowsiness among signs | Very common with insulin or sulfonylurea | Signs include difficulty concentrating and confusion |
| Fatigue | Above 0.4% in trials | Common | 2.6% (0.5 mg), 3.3% (1 mg) vs 1.4% |
| Dizziness | Above 0.4% in trials | Common | 2.8%, 3.1% vs 1.7%; most likely during dose increases |
| Dehydration after nausea, vomiting or diarrhoea | Warning 5.6 (kidney injury) | Section 4.4 warning | Post-marketing: dehydration |
| Brain fog, memory or concentration problems as a side effect | Not listed | Not listed | Not listed |
Low blood sugar: the explanation to rule out first
Semaglutide on its own rarely causes low blood sugar, but the risk rises sharply with insulin or a sulfonylurea [1]. In the US trials, documented symptomatic low blood sugar occurred in 17.3% on 0.5 mg and 24.4% on 1 mg when Ozempic® was combined with a sulfonylurea, and in 16.7% and 29.8% when added to basal insulin, against 15.2% on placebo with insulin [1]. Severe episodes, needing another person’s help, were seen in 1.2% with a sulfonylurea and 1.5% with insulin in the EU pool [2].
The EU and Canadian leaflets list feeling sleepy or weak, feeling nervous, anxious or confused, and difficulty concentrating among the warning signs, and say low blood sugar can affect your ability to drive [2][3]. MedlinePlus adds that unclear thinking tends to come with lower readings, and that some people have low blood sugar without noticing symptoms at all [5]. If your fog comes on before meals, after exercise or overnight, a glucose reading at that moment is the fastest way to know.
Other listed effects that blur thinking
Tiredness. The US label groups fatigue with taste change and dizziness among reactions above 0.4% [1]; the EU rates it common [2]; the Canadian table counts fatigue and weakness together at 2.6% and 3.3% versus 1.4% on comparators [3].
Dizziness. Canada notes that it can occur at first, during dose escalation, and advises against driving if it happens [3].
Dehydration. Section 5.6 links nausea, vomiting and diarrhoea to fluid loss and kidney injury [1]. MedlinePlus lists irritability or confusion, dizziness and a rapid heartbeat among signs of severe dehydration, and thirst, dry mouth and dark urine among milder ones [7].
High blood sugar and ketoacidosis. The EU leaflet reminds readers that Ozempic® is not insulin, and describes diabetic ketoacidosis with confusion, breathing difficulty, excessive thirst and sweet-smelling breath [2]. Canada lists it among reports after approval [3].
What studies on semaglutide and thinking show
A 2024 retrospective study drew on US electronic health records to follow adults with type 2 diabetes who started semaglutide between December 2017 and May 2021, matched one-to-one with people starting sitagliptin, empagliflozin or glipizide (19,206 to 23,386 per comparison) [4]. Across 22 neurological and psychiatric outcomes over 12 months, semaglutide was not associated with higher risk. A recorded cognitive deficit was about 28% less likely than with sitagliptin or glipizide (hazard ratio 0.72 for both) [4].
This was an exploratory, observational study without a pre-registered plan. It looked at diagnoses written in medical records, not at the day-to-day haziness people describe, and it cannot prove that semaglutide protects thinking. It does make it unlikely that semaglutide commonly causes measurable cognitive problems in people with diabetes.
What is proposed but unmeasured: eating much less, sleeping poorly because of nausea or reflux, or shifts in blood sugar during dose changes could each contribute to a foggy feeling. No Ozempic® trial tested these links directly.
Common causes unrelated to Ozempic®
Cleveland Clinic describes brain fog as a group of symptoms, including trouble focusing, forgetfulness, slow thinking and losing your train of thought, with many possible causes [6]:
- Not enough sleep, stress, and poor nutrition.
- Anxiety and depression.
- Hormonal changes, for example in pregnancy or menopause.
- Autoimmune conditions such as lupus, multiple sclerosis or fibromyalgia.
- Recovery after COVID-19, chemotherapy or a long hospital stay; and diabetes itself, including low blood sugar.
Steps general sources describe
Cleveland Clinic says there is no single treatment and lists general measures: better sleep habits, regular nutritious meals, daily physical activity, writing important things down, and short breaks through the day [6]. On Ozempic®, two label-based habits fit alongside: drinking fluids when stomach side effects strike, which the Medication Guide stresses, and knowing your plan for treating low blood sugar if you use insulin or a sulfonylurea [1].
Write down when the fog happens, how long it lasts, and, if you test, your glucose at the time. That turns a vague complaint into something your prescriber can act on.
Ozempic® points for your appointment
The label suggests that prescribers consider lowering a sulfonylurea or insulin dose when Ozempic® starts, precisely to reduce low blood sugar [1]. If fog began after starting Ozempic® or after a dose step, mention every diabetes medicine you take, any recent stomach upset and whether you drive for work. The EU leaflet says Ozempic® itself is unlikely to affect driving, but low blood sugar can [2].
Ozempic® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Confusion, drowsiness or trouble staying awake that does not improve after a sugary snack, or the person becomes less alert | Emergency services; do not drive yourself | Emergency | MedlinePlus [5] |
| Confusion with breathing difficulty, excessive thirst or sweet-smelling breath | Urgent medical care: the leaflet describes these as signs of diabetic ketoacidosis | Emergency | EU package leaflet [2] |
| Fog with sweating, shakiness, hunger or a fast heartbeat, especially with insulin or a sulfonylurea | Treat low blood sugar as you were shown, then call your prescriber | Today | Ozempic® Medication Guide [1] |
| Fog with very dark urine, little urine, dizziness or a racing heart after vomiting or diarrhoea | Your prescriber, the same day | Today | MedlinePlus [7], Ozempic® Medication Guide [1] |
| Dizziness or poor focus while driving or operating machinery | Stop driving and tell your prescriber | Today | Ozempic® Product Monograph [3] |
| Fog that interferes with work, appointments or daily tasks | Your clinician | At your next appointment | Cleveland Clinic [6] |
